The hardest revenue in business

I've worked across a lot of business models, and I'll say this plainly: hospitals and diagnostic labs have the hardest information problem of any of them. The revenue is the leakiest, the assets are the most expensive to leave idle, the inventory expires, and the workforce that drives the whole P&L is the least instrumented. Every part of the information stack is harder in healthcare than almost anywhere else.

That sounds like a warning. It's actually the opportunity. Because this is also one of the biggest wealth-creation journeys in the country right now: single hospitals and regional labs professionalising, raising private equity, and, increasingly, listing.

And in a sector where the information is this hard, the operators who master it don't just run better; they become the ones worth backing. Information discipline is the moat. Let me walk through why healthcare is so hard, stream by stream, and why that difficulty is exactly where the value is.

01The revenue doesn't fracture. It shatters.

In most businesses, "revenue" quietly means three slightly different things: what sales closed, what was delivered, what was collected. In healthcare, it shatters into many more, because of one brutal complication: the payer.

When a patient is treated, the money can come from any of several completely different sources, and each behaves in its own way:

• The cash patient, who pays quickly and cleanly.
• The insurance patient, whose bill goes through a TPA for pre-authorisation and then adjudication. It's a process measured in weeks, and a meaningful slice of what you billed comes back disallowed.
• The government schemes (Ayushman Bharat, CGHS, ESI and others), each with its own tariff, its own paperwork, and its own long lag before payment, if payment comes in full at all.

So in a hospital, "revenue booked" and "cash you will actually see" can be a quarter apart and a haircut lighter. The chain runs billed → approved → collected, and it leaks at every step.

A bill is raised; the payer approves less than the bill; the approved amount is collected months later, minus deductions nobody reconciled. Days in accounts receivable stretch and stretch. Claims get rejected on technicalities and never resubmitted. Revenue that looked real on the day of discharge quietly evaporates in the ninety days that follow.

Most hospitals I've looked at cannot see this clearly. They know what they billed. They have only a foggy view of what they'll actually approve and collect, split by payer, which means they're steering the business on a revenue number that isn't real.

Getting the Source and Measurement layers of the sales stream right in healthcare means one thing above all: seeing billed, approved, and collected separately, by payer, in something close to real time. Do that, and you can finally see your own business. Most can't, and don't.

03Inventory with a clock on it

Every physical business has an inventory problem: cash frozen in stock nobody can see. Healthcare has a worse version: inventory that expires.

Pharmacy stock, surgical implants and consumables, and, in diagnostics, lab reagents are all cash sitting on shelves. But unlike a warehouse of finished goods, much of it has a shelf life and a cold chain. Reagents degrade. Drugs expire. A cold-chain break writes off a batch instantly. So the money isn't just frozen; some of it quietly dies.

I've seen labs celebrate volume growth while their margins slid, and the answer sat in reagent cost per test and expiry that nobody was tracking: cash consumed by waste that never showed up as a line anyone watched.

Instrumenting this is the operations stream again: knowing what stock you hold and what it's worth, tracking consumption against revenue (reagent cost per test, pharmacy margin), and watching ageing and expiry like the cash risk they are.

In healthcare, inventory doesn't just hide cash. It destroys it on a timer.

05Why it all comes to a head: the raise

Every one of these problems stays survivable right up until the moment an outsider examines the business. And in healthcare, that moment is coming for more and more operators, because the sector is on a genuine capital journey.

Private equity is deeply active in Indian hospitals and diagnostic chains. Regional players are consolidating. And a listing, including the SME route, has gone from fantasy to realistic ambition for well-run mid-sized operators.

Here's the hard part: healthcare diligence is unusually brutal precisely on the things I've just described. A serious investor or acquirer will:

• Go straight at revenue quality: billed versus collected, receivables by payer, disallowance rates, ageing.
• Scrutinise related-party doctor payouts.
• Test whether your occupancy and ARPOB are real and sustainable, or flattered by averages.
• Check whether your reagent and pharmacy margins hold up.

And they will read the state of your information itself as a signal, because a hospital that can't show its own payer-split revenue on demand is telling them something about how the whole institution is run.

This is why, in this sector more than most, capital readiness cannot be assembled in the eleventh hour. The payer-wise revenue history, the clean receivables, the defensible clinician economics: these are years of disciplined information, or they're nothing.

The operators who build them don't just pass diligence; they command a premium, because in a sector this hard to read, provable numbers are rare and therefore valuable.